4
Changes in Ownership
Iambic Therapeutics, Inc. Filed Acc 0002155824-26-000005
Chief Scientific Officer acquired 19,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Olson Peter A Chief Scientific Officer | 2026-10-14 | Grant or award | +19,500 | 30,909 | D | ||
| Derivatives | |||||||
| Olson Peter A Chief Scientific Officer | 2026-10-14 | Grant or award · Employee Stock Option (right to buy) | +116,900 | 116,900 | D | ||
Loading xslF345X06/form4-10162026_081057.xml…